0001638599-17-000178.txt : 20170210 0001638599-17-000178.hdr.sgml : 20170210 20170210160513 ACCESSION NUMBER: 0001638599-17-000178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170208 FILED AS OF DATE: 20170210 DATE AS OF CHANGE: 20170210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBANY MOLECULAR RESEARCH INC CENTRAL INDEX KEY: 0001065087 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 141742717 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 CORPORATE CIRCLE STREET 2: P O BOX 15098 CITY: ALBANY STATE: NY ZIP: 12203-5154 BUSINESS PHONE: 5184640279 MAIL ADDRESS: STREET 1: 21 CORPORATE CIRCLE STREET 2: P O BOX 15098 CITY: ALBANY STATE: NY ZIP: 12203-5154 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gutierrez Fuentes Luis Gerardo CENTRAL INDEX KEY: 0001647975 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35622 FILM NUMBER: 17593212 MAIL ADDRESS: STREET 1: C/O ALBANY MOLECULAR RESEARCH, INC. STREET 2: 26 CORPORATE CIRCLE CITY: ALBANY STATE: NY ZIP: 02203 FORMER NAME: FORMER CONFORMED NAME: Gutierrez Fuentez Luis Gerardo DATE OF NAME CHANGE: 20150720 FORMER NAME: FORMER CONFORMED NAME: Fuentes Luis Gerardo Gutierrez DATE OF NAME CHANGE: 20150713 4 1 doc4_4519.xml PRIMARY DOCUMENT X0306 4 2017-02-08 0 0001065087 ALBANY MOLECULAR RESEARCH INC AMRI 0001647975 Gutierrez Fuentes Luis Gerardo C/O ALBANY MOLECULAR RESEARCH, INC. 26 CORPORATE CIRCLE ALBANY NY 12212 1 0 0 0 Common Stock 2017-02-08 4 A 0 3802 0 A 6656 D Common Stock 2200000 I See Footnote Option to Purchase Common Stock 18.41 2017-02-08 4 A 0 9358 0 A 2027-02-08 Common Stock 9358 9358 D These shares are held directly by 3-Gutinver, S.L., a company organized and existing under the laws of Spain. The Reporting Person is the Sole Administrator of 3-Gutinver, S.L. and may be deemed to beneficially hold these securities in such capacity. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed and admission that the Reporting Person is the beneficial owner of such securities for the purposes of Section 16 or any other purpose. Option is exercisable as to 1/3rd of the shares annually on the anniversary date of the grant for each of the next three years. /s/Lori M. Henderson, attorney-in-fact 2017-02-10